A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer.
about
MLK3 Signaling in Cancer InvasionMolecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case PresentationIdentification of breast cancer patients with a high risk of developing brain metastases: a single-institutional retrospective analysis.Maintenance treatment of trastuzumab for patients with advanced breast cancer to achieve long term survival: two case reports and literature review.Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer.Identification and characterization of a novel phage display-derived peptide with affinity for human brain metastatic breast cancer.Targeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigen.Anti-HER2 Therapy Beyond Second-Line for HER2-Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel.Precision treatment for cancer: role of prognostic and predictive markers.Advances in the approach to novel drug clinical development for breast cancer.Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues.Quantitative proteomics profiling reveals activation of mTOR pathway in trastuzumab resistance.Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).A Case of Breast Cancer Brain Metastasis with a 16-Year Time Interval without Evidence of Cancer Recurrence.Receptor change-clinicopathologic analysis of matched pairs of primary and cerebral metastatic breast cancer.CNS metastases in breast cancer patients: prognostic implications of tumor subtype.Pertuzumab, trastuzumab and docetaxel reduced the recurrence of brain metastasis from breast cancer: a case report.Drug resistance in HER2-positive breast cancer brain metastases: blame the barrier or the brain?Mechanisms and Therapy for Cancer Metastasis to the Brain.
P2860
Q26746892-CA0DCCB0-F6AF-4719-8FA0-41A1FD6EE38AQ26800626-92DB0C87-321F-4ED2-898E-0C932ACA7CECQ33553971-4426672C-4521-4AE0-9731-8FDEBE90F0E3Q34130140-6FE90671-8613-4F48-B784-B9F024125B89Q35011982-34544115-EDAE-4588-852A-8273DE264F81Q35210483-6D91106A-26CA-46E9-BF85-70357ACEC020Q35600421-E7206C2F-07E4-4B64-A82E-8D7B4593AEBFQ36938365-8EDB03AA-61BC-4393-8D19-4F0FD1BACD7BQ38179024-FCE42CF5-6562-4E32-A22E-9FAAFD53785EQ38206546-6FE8E78C-4E11-4C51-8DAD-E4B94F74CB3FQ38257364-0C436365-CDA5-4B82-B7F4-D9E2D995E0C1Q38703402-73C1691B-CC40-4012-97D6-BC43B1CCA804Q39229266-7B8751FD-F4DE-4BBA-826C-217A07DDCCC5Q40953860-8812D390-7A2B-4926-B564-609F6001B0C1Q44678963-8156A28D-0008-48BD-99D0-7F342777CAE9Q46011361-8770A2D6-F9F8-4D11-BB6F-FECCD1227C8BQ48106837-16102B87-F6FC-47BD-A73F-D8C2ABFD1F8AQ50043843-5B219AD3-95A3-453F-B051-87E8C243DA0AQ54950354-0A15E18E-1ED5-43CF-BF01-BC681AF5BD10
P2860
A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A systematic review of trastuz ...... m HER2-positive breast cancer.
@en
type
label
A systematic review of trastuz ...... m HER2-positive breast cancer.
@en
prefLabel
A systematic review of trastuz ...... m HER2-positive breast cancer.
@en
P2093
P1476
A systematic review of trastuz ...... m HER2-positive breast cancer.
@en
P2093
Dorte Lisbet Nielsen
Iben Kümler
Pia Bükmann Larsen
P304
P356
10.1016/J.CTRV.2013.01.006
P577
2013-03-05T00:00:00Z